Countries World

Asimov and Cytiva Unite to Fast-Track Complex Biologics Production

  Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell line development and c...

 April 30, 2025 | News

Henlius Licenses Ipilimumab Biosimilar HLX13 to Sandoz in $301M Global Deal

Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $...

 April 30, 2025 | News

RoosterBio and Thermo Fisher Partner to Accelerate Cell and Exosome Therapy Development

RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services,&n...

 April 30, 2025 | News

Eppendorf Enhances Automated Liquid Handling Efficiency With New epMotion® 4-Channel Tools

Eppendorf is expanding its product range in the field of automated liquid handling with the introduction of three new epMotion® 4-channel dispensing to...

 April 29, 2025 | News

Thermo Fisher Scientific Accelerates IND Timelines With Enhanced Platform and High-Yield CHO K-1 Cell Line

Enhanced platform technology and the addition of a robust, high-quality CHO K-1 cell line decreases lead time to Investigational New Drug (IND) Thermo Fis...

 April 29, 2025 | News

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

 April 28, 2025 | News

SimonMed Partners with Lunit to Advance AI-Powered Breast Cancer Detection Across the U.S.

 SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce thei...

 April 24, 2025 | News

Beckman Coulter Launches OptiMATE Gradient Maker to Speed Up Ultracentrifugation Workflows

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of the OptiMATE Gradient...

 April 24, 2025 | News

Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing

  Cell therapy stands at the forefront of modern medicine, offering transformative potential for treating a wide spectrum of diseas...

 April 22, 2025 | Report

VelaVigo Bio Signs $440M Global Licensing Deal with Ollin Biosciences for First-in-Class Bispecific Antibody VBS-102

VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specif...

 April 18, 2025 | News

Thermo Fisher Opens Advanced Therapies Collaboration Center in Carlsbad to Accelerate Cell Therapy Development

Thermo Fisher Scientific Inc., the world leader in serving science,  announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC...

 April 18, 2025 | News

Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals to Advance ADPKD Program

Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tami...

 April 16, 2025 | News

Thermo Fisher Launches 5L DynaDrive Single-Use Bioreactor to Accelerate Scalable Bioprocessing

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the 5L DynaDrive™ Single-Use Bioreactor (S.U.B.), designed to meet...

 April 15, 2025 | News

GPC-100, a CXCR4 Inhibitor, Moves Toward AML Trials Following Promising Preclinical and Phase 1 Data; Phase 2 in Multiple Myeloma Ongoing

Exicure, Inc. shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. (“Exicure”) is planning f...

 April 14, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close